Latest News
AstraZeneca and Oracle Health and Life Sciences announced a unique collaboration to leverage AstraZeneca's scientific, clinical development and regulatory expertise with Oracle's real-world data, cloud infrastructure, and AI-enabled clinical capabilities to accelerate clinical research and bring evidence-driven insights into care workflows to accelerate clinical trial optimisation and help more patients receive the right care sooner.
The U.S. Food and Drug Administration announced the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough treatments. NAIN is designed to advance the science, tools, and regulatory approaches needed to support the development of medical products for conditions affecting the brain and nervous system.A University at Buffalo researcher has developed this novel technology, called hexagonal micro-scaffold assisted spatial proteomics (hex-MASP), which has the potential to transform how researchers study and create new drugs.
The platform, called MAESTRO and described in Advanced Science, uses large language models, or LLMs, to analyze scientific knowledge about how drugs work and the biological pathways cancer cells use to survive treatment.
“The search for new antibiotics remains crucial, but we also need smarter ways to extend the lifespan of the antibiotics we already have.
Cabergoline, a medication used to stop milk production after pregnancy loss or when breastfeeding is not possible, is generally well tolerated by patients with few side effects. But it may also offer unexpected benefits.
The newly funded initiative, OpenPep, will lead to an open access database that will allow researchers to use artificial intelligence (AI) to predict which peptides will bind to target proteins.
The U.S. Food and Drug Administration today released final guidance establishing a clear framework for how drug companies can develop, distribute, and label apps used alongside their prescription medicines. The guidance ends longstanding uncertainty by providing recommendations about when app content is subject to FDA submission requirements, when an app should be mentioned on a drug’s official label, and what companies should submit to the agency.Cells from rapidly growing, highly metastatic tumors often contain numerous rings of extrachromosomal DNA (ecDNA).
Abbott, the global healthcare leader, launched “Mind Your Behind,” a new Cologuard Plus® awareness campaign featuring baseball legend and three-time MVP Albert “The Machine” Pujols and catcher for the Seattle Mariners Cal “The Big Dumper” Raleigh to encourage adults to prioritize colorectal cancer screening.A Curtin University-led group of international researchers is calling for stronger health policy action to arrest the growing global disability burden.
Pharmaceutical companies use a variety of strategies to market and promote their drugs.
